Access to Scalp Cooling Therapy Act of 2024

Bill 118 hr 8128, also known as the Access to Scalp Cooling Therapy Act of 2024, is a piece of legislation currently being considered by the US Congress. The purpose of this bill is to improve access to scalp cooling therapy for cancer patients undergoing chemotherapy treatment.

Scalp cooling therapy is a treatment that can help prevent hair loss in cancer patients receiving chemotherapy. This therapy works by cooling the scalp, which can reduce blood flow to the hair follicles and minimize the amount of chemotherapy drugs that reach the hair cells. This can help patients retain their hair during treatment, which can have a positive impact on their self-esteem and overall well-being.

The Access to Scalp Cooling Therapy Act of 2024 aims to make this treatment more accessible to cancer patients by requiring insurance companies to cover the cost of scalp cooling therapy for eligible patients. The bill also includes provisions to increase awareness of scalp cooling therapy among healthcare providers and patients, as well as funding for research into the effectiveness of this treatment. Overall, this bill seeks to improve the quality of life for cancer patients undergoing chemotherapy by ensuring they have access to scalp cooling therapy. It is an important step towards providing comprehensive care for cancer patients and addressing the emotional and psychological impact of hair loss during treatment.